Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Management and Research|May 27, 2021
Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung CancerXiaofei Yu, Zhengwei Dong, Wanying Wang, et al.Translational Lung Cancer Research|September 21, 2020
CD39: the potential target in small cell lung cancerShanhao Chen, Shengyu Wu, Liping Zhang, et al.Cancer Immunology, Immunotherapy : CII|June 7, 2021
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLCShiqi Mao, Fei Zhou, Yiwei Liu, et al.Annals of Palliative Medicine|April 9, 2021
Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a narrative reviewXinxin Ying, Nuo Ma, Xuehan Zhang, et al.Thoracic Cancer|February 24, 2024
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung diseaseChuchu Shao, Xinxin Zhi, Shiqi Mao, et al.Science Advances|May 26, 2023
PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillanceChangsheng Huang, Shengxiang Ren, Yaqi Chen, et al.Annals of Translational Medicine|August 5, 2021
Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative reviewYiyi Cai, Boyuan Wang, Bingying Li, et al.Lung Cancer (Amsterdam, Netherlands)|May 18, 2023
Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusionYingying Pan, Xinyu Liu, Wei Zhang, et al.Translational Lung Cancer Research|May 19, 2020
Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19Haoyue Guo, Xiaoxia Chen, Chunxia Su, et al.Cancer Cell|June 28, 2024
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancerCaicun Zhou, Chongyang Li, Libo Luo, et al.Pageof 3